0001179110-21-005054.txt : 20210510 0001179110-21-005054.hdr.sgml : 20210510 20210510162950 ACCESSION NUMBER: 0001179110-21-005054 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200602 FILED AS OF DATE: 20210510 DATE AS OF CHANGE: 20210510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOREVIC JASON N CENTRAL INDEX KEY: 0001208500 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 21907663 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4/A 1 edgar.xml FORM 4/A - X0306 4/A 2020-06-02 2020-06-05 0 0001477449 Teladoc Health, Inc. TDOC 0001208500 GOREVIC JASON N C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 1 1 0 0 Chief Executive Officer Common Stock 2020-06-02 2020-06-03 4 M 0 23067 1.67 A 694350 D Common Stock 2020-06-02 2020-06-03 4 M 0 1933 6.01 A 696283 D Common Stock 2020-06-02 2020-06-03 4 S 0 1600 165.6013 D 694683 D Common Stock 2020-06-02 2020-06-03 4 S 0 3899 166.7333 D 690784 D Common Stock 2020-06-02 2020-06-03 4 S 0 4916 167.7042 D 685868 D Common Stock 2020-06-02 2020-06-03 4 S 0 5791 168.796 D 680077 D Common Stock 2020-06-02 2020-06-03 4 S 0 7794 169.6574 D 672283 D Common Stock 2020-06-02 2020-06-03 4 S 0 600 170.4133 D 671683 D Common Stock 2020-06-02 2020-06-03 4 S 0 100 171.32 D 671583 D Common Stock 2020-06-02 2020-06-03 4 S 0 300 172.58 D 671283 D Employee Stock Option (right to buy) 1.67 2020-06-02 2020-06-03 4 M 0 23067 0.00 D 2023-12-11 Common Stock 23067 0 D Employee Stock Option (right to buy) 6.01 2020-06-02 2020-06-03 4 M 0 1933 0.00 D 2024-12-22 Common Stock 1933 120310 D The reporting person was informed by the broker of the reported transactions on June 3, 2020. Accordingly, pursuant to Rule 16a-3(g)(2), the deemed execution date was June 3, 2020. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2020. Represents the weighted average price of transactions ranging from $165.23 to $166.13, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 8 to this Form 4. Represents the weighted average price of transactions ranging from $166.24 to $167.11, inclusive. Represents the weighted average price of transactions ranging from $167.25 to $168.24, inclusive. Represents the weighted average price of transactions ranging from $168.27 to $169.26, inclusive. Represents the weighted average price of transactions ranging from $169.28 to $170.27, inclusive. Represents the weighted average price of transactions ranging from $170.31 to $170.51, inclusive. The option vested as to 25% of the shares on January 1, 2014. The remainder of the shares vested in 36 substantially equal monthly installments thereafter. The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vested in 36 substantially equal monthly installments thereafter. Note: This Form 4 amendment is being filed to amend the previous Form 4 filed on June 5, 2020 to include the Deemed Execution Date of June 3, 2020, which was previously omitted. /s/ Adam C. Vandervoort, attorney-in-fact 2021-05-10